Audit Committee Charter
Compensation Committee Charter
Corporate Code of Conduct and Ethics
Nominating and Governance Committee Charter
Policy on Security Holder Communications with Directors
Resmetirom is an investigational therapy and has not been approved by the FDA (or any other regulatory authority). Resmetirom
is only available for use in a clinical trial setting (ClinicalTrials.gov NCT03900429 and NCT04197479)
Website Developed by Alan Leff Associates, Inc.